Rare diseases
Investigational molecules
Locations
Back to France1 099 clinical trials in Montpellier, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer
FranceStudy Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
FranceStudy on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis
FranceStudy of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease
FranceStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
FranceStudy of Baricitinib for Children and Adolescents with Moderate-to-Severe Atopic Dermatitis
FranceStudy of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression
FranceStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
FranceStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
FranceStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
FranceStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
FranceStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancer, bladder cancer, and mantle cell lymphoma. Studies evaluate combination therapies and novel treatment approaches for improved patient outcomes.
Research includes evaluation of immunotherapy combinations and targeted molecular approaches.
Studies examining innovative treatments for Crohn's disease, multiple sclerosis, and systemic sclerosis. Research focuses on novel therapeutic approaches and treatment optimization.
Trials aim to improve disease management and patient quality of life.
Investigating treatments for achondroplasia, pyruvate dehydrogenase deficiency, and thyroid eye disease. Focus on developing targeted therapies for these uncommon conditions.
Research aims to address unmet medical needs in rare disease populations.
Clinical trials evaluating vaccines for cytomegalovirus, yellow fever, and HPV prevention. Studies focus on immunization effectiveness and safety profiles.
Research emphasizes disease prevention and public health improvement.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
